3-(Dimethylamino)-1-(1,3-oxazol-2-yl)prop-2-en-1-one, 97.0%, 5g

1H,1H,2H,2H-Nonafluorohexyl Methacrylate (stabilized with MEHQ)>98.0%(GC)5g

2-Chloro-6-((4-methoxybenzyl)oxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 250mg

(7-Methoxy-2-methyl-1H-indol-3-yl)-acetic acid, 95.0%, 500mg

Ethyl 5-Chloro-1H-pyrrolo-[2,3-c]-pyridine-2-carboxylate, 98.0%, 100mg

3,5-dimethyl 1-benzyl-4-oxo-2,6-bis(pyridin-2-yl)piperidine-3,5-dicarboxylate, 5g

3-Ethyl-2-methyl-1,5,6,7-tetrahydroindol-4-one, 97.0%, 250mg

7-Methoxy-1H-benzo[d]imidazole, 95.0%, 10g

(3-(Dibenzo[b,d]thiophen-4-yl)phenyl)boronic acid, 97%, 5g

1-(p-Tolyl)prop-2-yn-1-ol, 95.0%, 1g

TRANS-HEXAHYDRO-CYCLOPENTA[C]PYRROLE-2,5-DICARBOXYLIC ACID MONO-TERT-BUTYL ESTER, 95.0%, 1g

[4-(methoxymethoxy)phenyl](pyridin-4-yl)methanone, 95.0%, 250mg

(S)-2-Azabicyclo[2.2.2]octane-3-carboxylic acid, 95.0%, 250mg